224 related articles for article (PubMed ID: 35595022)
1. The effects of protein corona on in vivo fate of nanocarriers.
Xiao Q; Zoulikha M; Qiu M; Teng C; Lin C; Li X; Sallam MA; Xu Q; He W
Adv Drug Deliv Rev; 2022 Jul; 186():114356. PubMed ID: 35595022
[TBL] [Abstract][Full Text] [Related]
2. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
Liu N; Tang M; Ding J
Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
[TBL] [Abstract][Full Text] [Related]
3. Research progress and application opportunities of nanoparticle-protein corona complexes.
Huang W; Xiao G; Zhang Y; Min W
Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
Moraru C; Mincea M; Menghiu G; Ostafe V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
[TBL] [Abstract][Full Text] [Related]
5. Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona.
Schöttler S; Landfester K; Mailänder V
Angew Chem Int Ed Engl; 2016 Jul; 55(31):8806-15. PubMed ID: 27303916
[TBL] [Abstract][Full Text] [Related]
6. Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins.
Weber C; Simon J; Mailänder V; Morsbach S; Landfester K
Acta Biomater; 2018 Aug; 76():217-224. PubMed ID: 29885856
[TBL] [Abstract][Full Text] [Related]
7. Biological effects of formation of protein corona onto nanoparticles.
Mishra RK; Ahmad A; Vyawahare A; Alam P; Khan TH; Khan R
Int J Biol Macromol; 2021 Apr; 175():1-18. PubMed ID: 33508360
[TBL] [Abstract][Full Text] [Related]
8. Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.
García Vence M; Chantada-Vázquez MDP; Vázquez-Estévez S; Manuel Cameselle-Teijeiro J; Bravo SB; Núñez C
Clin Chim Acta; 2020 Feb; 501():102-111. PubMed ID: 31678275
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins on the surface of differently charged polymer nanoparticles.
Prozeller D; Rosenauer C; Morsbach S; Landfester K
Biointerphases; 2020 Jun; 15(3):031009. PubMed ID: 32486649
[TBL] [Abstract][Full Text] [Related]
10. Unveiling the pitfalls of the protein corona of polymeric drug nanocarriers.
Berrecoso G; Crecente-Campo J; Alonso MJ
Drug Deliv Transl Res; 2020 Jun; 10(3):730-750. PubMed ID: 32152965
[TBL] [Abstract][Full Text] [Related]
11. Looking back, moving forward: protein corona of lipid nanoparticles.
Gao Y; Huang Y; Ren C; Chou P; Wu C; Pan X; Quan G; Huang Z
J Mater Chem B; 2024 Jun; 12(23):5573-5588. PubMed ID: 38757190
[TBL] [Abstract][Full Text] [Related]
12. Modulating the toxicity of engineered nanoparticles by controlling protein corona formation: Recent advances and future prospects.
Wang J; Xu Y; Zhou Y; Zhang J; Jia J; Jiao P; Liu Y; Su G
Sci Total Environ; 2024 Mar; 914():169590. PubMed ID: 38154635
[TBL] [Abstract][Full Text] [Related]
13. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
Shang L; Nienhaus GU
Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
[TBL] [Abstract][Full Text] [Related]
14. The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome.
Pisani C; Gaillard JC; Odorico M; Nyalosaso JL; Charnay C; Guari Y; Chopineau J; Devoisselle JM; Armengaud J; Prat O
Nanoscale; 2017 Feb; 9(5):1840-1851. PubMed ID: 27858044
[TBL] [Abstract][Full Text] [Related]
15. Gold nanoparticle should understand protein corona for being a clinical nanomaterial.
Charbgoo F; Nejabat M; Abnous K; Soltani F; Taghdisi SM; Alibolandi M; Thomas Shier W; Steele TWJ; Ramezani M
J Control Release; 2018 Feb; 272():39-53. PubMed ID: 29305922
[TBL] [Abstract][Full Text] [Related]
16. Preparation of the protein corona: How washing shapes the proteome and influences cellular uptake of nanocarriers.
Brückner M; Simon J; Jiang S; Landfester K; Mailänder V
Acta Biomater; 2020 Sep; 114():333-342. PubMed ID: 32726673
[TBL] [Abstract][Full Text] [Related]
17. Formation and biological effects of protein corona for food-related nanoparticles.
Cui G; Su W; Tan M
Compr Rev Food Sci Food Saf; 2022 Mar; 21(2):2002-2031. PubMed ID: 34716644
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
Ahsan SM; Rao CM; Ahmad MF
Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
[TBL] [Abstract][Full Text] [Related]
19. Protein-Nanoparticle Interaction: Corona Formation and Conformational Changes in Proteins on Nanoparticles.
Park SJ
Int J Nanomedicine; 2020; 15():5783-5802. PubMed ID: 32821101
[TBL] [Abstract][Full Text] [Related]
20. Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles.
Lima T; Bernfur K; Vilanova M; Cedervall T
Sci Rep; 2020 Jan; 10(1):1129. PubMed ID: 31980686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
